1st Quarter - Report

TIBER CREEK GROUP for GILEAD SCIENCES, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Issues related to international trade; Issues related to intellectual property protections for COVID-19 treatments; Issues related to the TRIPS Waiver; Global supply chain issues, including S. 998 - Medical Supply Chain Resiliency Act; Issues related to compulsory licensing and other intellectual property issues in multiple countries.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —

Contacted: HOUSE OF REPRESENTATIVES

Bills named: S. 998 (119th)

Health Issues HCR

Issues related to implementation of drug pricing and reimbursement for prescription drugs in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to HIV; Issues related to the implementation of the American Relief Act of 2025 (PL 118-158).

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
BRYANT HALL —
JONATHON JONES —
MATTHEW LEFFINGWELL —
COREY MALMGREN —
JENNIFER OLSON New Legislative Director, Sen. Lindsey Graham (2005-2010); Legislative Assistant, Sen. Graham (2003-2005); Legislative Assistant, Rep. Jim Kolbe (2001-2003).

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Issues related to implementation of drug pricing and reimbursement for prescription drugs in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the implementation of the American Relief Act of 2025 (PL 118-158).

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
BRYANT HALL —
JONATHON JONES —
COREY MALMGREN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.